Safety is a key concern among health officials and experts. Before the FDA approves a vaccine, the manufacturer must do rigorous research and testing to ensure the vaccine’s safety and effectiveness. The FDA independently reviews and verifies the information from these tests. It then decides whether the vaccine can be licensed and given to the public.
For each vaccine authorized by the FDA, the Advisory Committee on Immunization Practices (ACIP) carefully reviews all available data about the vaccine from clinical trials and other studies and makes recommendations for vaccine use in the general public. Recommendations include groups that should and should not receive the vaccine, as well as the timing, volume, number, and spacing of doses in a vaccine series.
The FDA and CDC continue to closely monitor vaccine safety after the public begins using the vaccine. Both agencies have longstanding and new safety systems in place for heightened monitoring of all COVID-19 vaccines.Georgia Department of Public Health Vaccine FAQs